Thanks, Bryan. Everyone can follow along the chart presentation. We will start on Page 3, where we have the overall financial highlights of the fourth quarter. As you can see, we had a great quarter for orders with an increase of 39%, which resulted in record backlog at year end. All three businesses had good order results with A&D being particularly strong. Sales in the quarter were up over 6%. Adjusted EBIT dollars were up 3%. And adjusted earnings per share were also up 3%. We will go through the segment details in a minute, but on the sales side, the utility solutions group delivered exceptional sales growth, while A&D had more modest growth and the test business was down. Overall, margins declined in the quarter. Two of the three businesses had margin increases, but declines at A&D led to an overall reduction. Moving to Chart 4, we'll start now on the segment details beginning with A&D. Starting with orders, you can see that they've increased significantly to over $177 million in Q4. Navy orders at Globe and VACCO were a key driver of the increase, but we continue to see strength from the aircraft component businesses as well. On the sales side, organic sales were flat and the CMT acquisition added 3 points of growth. Defense aerospace led the growth, followed by Navy and commercial aerospace. Space sales declined significantly. The space decline is driven by margin erosion on a number of development contracts. This is the issue Bryan mentioned in the overview, and it is also the driver of the down EBIT dollars and margins for A&D in the quarter. Outside of the space business, we saw some very good increases in profitability from the aircraft component businesses. On Chart 5, we have the utility solutions group. Orders were up 11% with the utility business at Doble driving the increase. The renewables orders at NRG were down in Q4 after the first three quarters experience growth rates above 30%. Obviously, we'll continue to monitor the renewables business going forward, but we expect good growth there as we move into 2024. Sales in the quarter were up over 22%, and as you see on the chart, the Doble protection testing product lines were the key driver. On the renewable side with NRG, we once again saw explosive growth, 69% in the quarter as the business reduced backlog after a significant build during the first three quarters. The top line performance converted to nice margin expansion with adjusted EBIT up 200 basis points. This improvement was driven by leverage on the higher sales growth and favorable impacts from price increases. On Chart 6, we have the test business, where orders increased 9% compared to last year's fourth quarter. On the sales line, we did see a reduction of 8% as we continue to see weakness in China, and also some softness in the domestic power filter sales. EBIT dollars declined nearly 6%, but the EBIT margins did increase from 17% to 17.5%, a good result on profitability given the drop in sales volumes. On Chart 7, we have a few details on the MPE acquisition. This closed last week on November 9th, and Bryan did preview this a bit, but a real nice tuck-in deal for the test business. MPE is a UK-based business that specializes in electronic filters. These can be whole facility filters or component filters embedded in military or other critical applications. The business has a good sales presence in Europe and the US, while adding high margin component content to our existing test platform. We're excited to have MPE on board and feel they will be a great addition to ESCO. On Chart 8, we have key measurables for the full year. As Bryan mentioned earlier, it's another record year for us in 2023, and this chart shows that trend nicely. Orders increasing to up over $1 billion, sales up 11.5% to $956 million, a nice improvement in adjusted EBIT margins, and adjusted earnings per share of over 15%. Next is Chart 9 with the full year results by segment. The sales momentum in 2023 really came from the A&D and USG businesses, while test was down slightly for the full year. For A&D sales, the key driver was commercial and military aerospace, which delivered 19% and 32% growth, respectively. For utility, there was broad-based growth with condition monitoring, protection testing, and renewables leading the way. Lastly for tests, the full year decline was driven by volume drops in China which were not offset by strength in Europe. On the margin side, USG led the way with a margin increase of 160 basis points. Test was also able to increase margins in spite of the reduced sales. Lastly, A&D margins fell as strong performance from the aircraft component businesses was offset by challenges in the space business. The last chart on 2023 is number 10 where we have the cash flow highlights. The operating cash flow dropped to approximately $77 million in 2023. Cash flow continued to be a challenge throughout the year. The biggest challenges were with the A&D business, where we continued to see elevated levels of past due backlog. This tied up more cash and working capital, and was the key driver of the cash decline in 2023. You can also see we had unfavorable cash impacts from increased tax and interest payments during the year. Capital expenditures were down by approximately $10 million during 2023. You'll recall that last year we had a building purchase at NRG and that's the main driver of this year's decrease. Acquisition spending was up approximately $7 million, with NEco acquired by PTI in fiscal 2022, and CMT acquired by Globe in fiscal 2023. Lastly is share repurchase, where we completed just over $12 million in buybacks this year compared to approximately $20 million last year. The last chart is our 2024 guidance. You can see on the graphs at the bottom of the chart that we've had two strong years of growth in 2022 and 2023 and the outlook for ESCO remains strong as we expect to deliver another double-digit earnings increase for 2024. For sales we expect an increase in the range of 7% to 9%. The sales growth forecast is balanced by business with A&D both projected to grow in the 8% to 10% range. The Test range includes the impact of the MPE acquisition. USG is expected in the 6% to 8% range, all solid numbers after two good years of growth in 2022 and 2023. You can see from the chart that we are projecting adjusted earnings per share growth in the range of 11% to 16% for a range of $4.10 to $4.30 per share. This would be the third year in a row of double-digit growth and adjusted earnings per share for ESCO. As is typically the case, we expect the business to ramp sequentially as we move through the year and we expect Q1 earnings per share to be in a range of $0.64 to $0.70 per share. That concludes the financial update. And now, I'll turn it back over to Bryan.